- Lobbying
- Zach AND Williams
Lobbying Arrangements Results for 'Zach Williams'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Telecom, Communications Opportunity, Promotion and Enhancement Act of 2006. |
Bellsouth, Inc.
Telecommunications Company |
Cauthen Forbes & Williams | |||
Details Issues related to the opioid crisis. |
Virpax Pharmaceuticals
|
Forbes-Tate | |||
Details Issues related to CMS coverage of medical devices. |
Kimbell & Associates on behalf of Heartware
|
Forbes-Tate | |||
Details Issues related to the opioid crisis; Issues related to NIH funding; Issues related to wound care. |
MilanaPharm
|
Forbes-Tate | |||
Details Issues related to health insurance plans; Issues related to insurance tax and Medicare Advantage; Issues related to TRICARE; Issues related to Medical Loss Ratio. Issues related to anti-trust; issu... |
UnitedHealth Group, Inc.
|
CAUTHEN FORBES & WILLIAMS | |||
Details Issues pertaining to the energy industry; issues pertaining to Section 179 - production tax credit and accreted depreciation; issues related to "coal ash" regulation; issues related to energy effic... |
NorthWestern Energy
|
CAUTHEN FORBES & WILLIAMS | |||
Details S 3663: Clean Energy Jobs and Oil Company Accountability Act of 2010, Omnibus SA 4845: Americas Great Outdoors Act of 2010 (Amendment to S 303), and HR 4853: Tax Relief, Unemployment Insurance Rea... |
The Nature Conservancy
|
CAUTHEN FORBES & WILLIAMS | |||
Details Issues pertaining to the wireless telecommunications industry and broadband spectrum policy; issues related to shipment of lithium batteries; issues related to bonus depreciation; issues related to... |
Cauthen Forbes & Williams on behalf of CTIA The Wireless Association
|
Forbes-Tate | |||
Details Issues related to the malt beverage industry and packaging; Issues surrounding the Federal Beer Excise Tax, H.R. 1161 - Community Alcohol Regulatory Effectiveness Act of 2011; Issues Related to the... |
Anheuser-Busch
|
CAUTHEN FORBES & WILLIAMS | |||
Details Issues related to drug approval. Issues related to FDA draft guidances. Issues related to pharmaceutical reimbursement; issues related to intellectual property and drug counterfeiting; issues relat... |
Allergan USA, Inc.
|
Forbes-Tate | |||
Details Issues regarding "Medicare for All" related proposals. |
The Partnership for Americas Health Care Future
|
Forbes-Tate | |||
Details Issues related to cosmetics. |
Evolus Beauty
|
Forbes-Tate | |||
Details Issues related to drug pricing; Issues related to 340b; Issues related to trade; Issues related to tax; Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). |
Bayer Corporation
|
Forbes-Tate | |||
Details Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. |
Verde Technologies
|
Forbes-Tate | |||
Details Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Drug pricing Issues related to implementation of the Inflation Reduction Act of 2022 (P... |
Sanofi U.S.
|
Forbes-Tate | |||
Details Issues related to the implementation of international tax and tax reform (PL 115-97); Issues related to Puerto Rico tax; Issues related to the implementation of the Inflation Reduction Act of 2022 ... |
Amgen USA, Inc.
|
Forbes-Tate | |||
Details Issues related to broadband spectrum policy, the incentive auction, net neutrality, 5G deployment, rural broadband, and privacy; Supply chain related issues; Issues related to privacy. Issues relat... |
CTIA - The Wireless Association
|
Forbes-Tate | |||
Details Issues related to the sequestration of corporate alternative minimum tax refunds, IRC. sections 168(k)(4) and 53(e). |
AMT Refund Coalition
|
The Washington Tax & Public Policy Group (formerly The Washington Tax Group) | |||
Details Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of C... |
Novartis, Inc.
|
Forbes-Tate | |||
Details Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending ... |
Emergent Biosolutions
|
Forbes-Tate | |||
Details Issues related to energy transmission and distribution, corporate tax reform and energy tax initiatives. Issues related to energy transmission, energy distribution, energy generation, customer comm... |
NorthWestern Corporation dba NorthWestern Energy
|
in-house lobbying | |||
Details FY24 Labor, Health and Human Services, and Education Appropriations Bill: Pediatric Subspecialty Loan Repayment Program, Firearm Injury and Mortality Prevention Research, Pediatric Mental Health Ca... |
AMERICAN ACADEMY OF PEDIATRICS
|
in-house lobbying | |||
Details FY21 Transportation-HUD and Related Agencies Appropriations (Bills Pending), provisions relating to the funding of the Administration's budget request for air traffic control modernization. Spect... |
Raytheon Company
|
in-house lobbying | |||
Details H.R. 2670/S. 2226 - National Defense Authorization Act FY24, H.R. 4365/S. 2587 - Department of Defense Appropriations Act FY24 and H.R. 3932/S. 2103 - Intelligence Authorization Act FY24; provision... |
RTX Corporation and Affiliates
|
in-house lobbying | |||
Details S.Con.Res.2 - A concurrent resolution commending the bravery, courage, and resolve of the women and men of Iran demonstrating in more than 133 cities and risking their safety to speak out against t... |
J Street
|
in-house lobbying |